FDA BLOOD PRODUCTS ADVISORY COMMITTEE SHOULD INCLUDE INDUSTRY, ASSOCIATION TELLS HOUSE HEARING; REP. SHAYS PLANS MORE HEARINGS ON BLOOD SAFETY
Executive Summary
The plasma collection and fractionation industry should be represented on FDA's Blood Products Advisory Committee, American Blood Resources Association President James Reilly told a Nov. 2 hearing on blood safety before the House Government Reform/Human Resources Subcommittee.